 |
 |
About Millenia Millenia Hope is committed to improving the quality of life through cures for global diseases. We apply novel approaches, based on natural sourced products, initially focusing on malaria and AIDS. |
| ABOUT MILLENIA |
| CLINICAL STUDIES |
| KEY MANAGEMENT PERSONNEL |
| BOARD OF DIRECTORS |
| SCIENTIFIC ADVISORY BOARD |
| SALES AUTHORIZATION |
About Millenia
Millenia Hope is a biopharmaceutical company focused on comprehensive solutions to the problem of world disease. The company’s objective is to fight disease through a portfolio of health products, developed by Millenia Hope and its team of clinical associates based around the world. Millenia Hope utilizes traditional, natural sourced treatments to discover and develop innovative pharmaceutical products. The Company is focused on parasitic diseases, particularly malaria, and AIDS and other infectious diseases, both viral and bacterial, devastating the world’s future generations. To this end Millenia has launched its first product, MMH™ Malarex/MMH™ 18, an all natural anti-malarial treatment and is developing SAR for compounds to treat AIDS, scpecifically targeting HIV-1 RNase H.
About Malarex